
Sign up to save your podcasts
Or
In this episode of the Talking Blood Cancer podcast, host Maryanne Skarparis sits down with Associate Professor Dr James Morton to provide an in-depth look at blood and bone marrow transplantation in the treatment of leukaemia and related blood cancers.
Dr Morton shares what led him to specialise in transplant medicine, reflecting on early experiences that sparked his interest in how donor immune systems can contribute to curing blood cancers like leukaemia. He explains, the key considerations involved in assessing whether a patient is suitable for transplant, including age, overall fitness, and the risk of the cancer returning.
They explore topics such as graft versus host disease (GVHD), donor matching (including the process and significance of HLA typing), and advances in post-transplant care aimed at reducing complications. Dr Morton provides advice for patients and families about fertility preservation for both men and women, including the timing and processes involved before undergoing intensive therapies.
They discuss the emerging field of cellular therapies, such as CAR T-cell therapy, and how these treatments are being used to further harness the immune system to fight blood cancers. Dr Morton shares his perspective on patient decision-making, especially when weighing the risks and benefits of transplantation, and the importance of clear, informed consent for all involved.
Dr Morton and Maryanne emphasise the value of communication, support, and understanding not only for patients but also for families and carers navigating the complexities of blood cancer treatment and transplant recovery.
For more information about the Leukaemia Foundation visit: https://www.leukaemia.org.au
The Talking Blood Cancer Podcast is brought to you by the Leukaemia Foundation and is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network
In this episode of the Talking Blood Cancer podcast, host Maryanne Skarparis sits down with Associate Professor Dr James Morton to provide an in-depth look at blood and bone marrow transplantation in the treatment of leukaemia and related blood cancers.
Dr Morton shares what led him to specialise in transplant medicine, reflecting on early experiences that sparked his interest in how donor immune systems can contribute to curing blood cancers like leukaemia. He explains, the key considerations involved in assessing whether a patient is suitable for transplant, including age, overall fitness, and the risk of the cancer returning.
They explore topics such as graft versus host disease (GVHD), donor matching (including the process and significance of HLA typing), and advances in post-transplant care aimed at reducing complications. Dr Morton provides advice for patients and families about fertility preservation for both men and women, including the timing and processes involved before undergoing intensive therapies.
They discuss the emerging field of cellular therapies, such as CAR T-cell therapy, and how these treatments are being used to further harness the immune system to fight blood cancers. Dr Morton shares his perspective on patient decision-making, especially when weighing the risks and benefits of transplantation, and the importance of clear, informed consent for all involved.
Dr Morton and Maryanne emphasise the value of communication, support, and understanding not only for patients but also for families and carers navigating the complexities of blood cancer treatment and transplant recovery.
For more information about the Leukaemia Foundation visit: https://www.leukaemia.org.au
The Talking Blood Cancer Podcast is brought to you by the Leukaemia Foundation and is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network